| Abstract: |
A composition and method for the use of Panax quinquefolius for the attenuation of Cannabis-induced dysphoria where dosage can be effectively administered in a gum base cold pressed into a tablet containing at least 300 mg of Panax quinquefolius and Maltitol, Sorbitol, Isomalt, Xylitol, natural & artificial flavors, vegetarian magnesium stearate, Sucralose and Silicon dioxide. |
| Inventor: |
Epner, Paul (San Diego, CA, US); Zimmer, III, Richard (Mandeville, LA, US); Massey, Bill W. (Heber Springs, AR, US) |
| Applicant: |
ENGEN MEDICAL CORPORATION (San Diego, CA, US) |
| Face Assignee: |
ENGEN MEDICAL CORPORATION (San Diego, CA, US) |
| Filed: |
2018-01-05 |
| Issued: |
2019-07-16 |
| Claims: |
1 |
|
US10350253
|
1. A method to reverse the intoxication in a human intoxicated by cannabis use consisting essentially of administering to said human a therapeutically effective amount of a composition of Panax quinquefolius where the amount of Panax quinquefolius is at least 300 mg in the composition and the composition is a chewing gum. (0)
|
|
